CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company
Edesa Biotech, Inc.
Sign in to watch- Ticker
- EDSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (905) 475-1234
- Business address
- C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
- Former names
- Stellar Biotechnologies, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Other events
- 4 Other acquisition Chief Executive Officer acquired 371,727 shares (other)
- SC 13D/A Stake Beneficial Ownership Report
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market buy President bought 2,500 shares at an average $3.00 ($7,499)
- 4 Open-market buy Chief Executive Officer bought 3,000 shares at $2.98 ($8,939)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Bylaws or fiscal year change · Other events
- 8-K Event Other events
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
Page 18 of 38 · 753 filings